ZBH
Zimmer Biomet·NYSE
--
--(--)
--
--(--)
3.80 / 10
Netural
Technical assessment gives ZBH a 3.8/10 neutral rating. RSI is overbought, offering slight bullish bias, but a MACD death cross introduces bearish pressure. Recent signals are scarce, creating volatility and an unclear short‑term direction.
Analysis Checks(1/2)
RSI Overbought
Score6.26/10
Win Rate61.54%
Hist. Signals13
Avg Return0.20%
Score6.26/10
Win Rate61.54%
Hist. Signals13
Avg Return0.20%
MACD Death Cross
Score1.35/10
Win Rate41.67%
Hist. Signals12
Avg Return-2.33%
Score1.35/10
Win Rate41.67%
Hist. Signals12
Avg Return-2.33%
RSI Overbought
Score6.26/10
Win Rate61.54%
Hist. Signals13
Avg Return0.20%
Score6.26/10
Win Rate61.54%
Hist. Signals13
Avg Return0.20%
MACD Death Cross
Score1.35/10
Win Rate41.67%
Hist. Signals12
Avg Return-2.33%
Score1.35/10
Win Rate41.67%
Hist. Signals12
Avg Return-2.33%
What is the current technical signals for ZBH?
- ZBH presents a Netural setup with a Technical Score of 3.80/10. Key technical indicators highlight an RSI of 36.52 and a MACD of -1.82, with the trend anchored by the 50-Day SMA at 91.85. Traders should monitor key support at 85.51 and resistance at 87.44.
